Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Cash from Investing Activities (2020 - 2023)

Historic Cash from Investing Activities for Candel Therapeutics (CADL) over the last 4 years, with Q4 2023 value amounting to -$27000.0.

  • Candel Therapeutics' Cash from Investing Activities rose 9021.74% to -$27000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was -$280000.0, marking a year-over-year increase of 7841.17%. This contributed to the annual value of -$16000.0 for FY2024, which is 9428.57% up from last year.
  • Per Candel Therapeutics' latest filing, its Cash from Investing Activities stood at -$27000.0 for Q4 2023, which was up 9021.74% from -$103000.0 recorded in Q3 2023.
  • In the past 5 years, Candel Therapeutics' Cash from Investing Activities registered a high of $20.2 million during Q4 2020, and its lowest value of -$732000.0 during Q3 2020.
  • Over the past 4 years, Candel Therapeutics' median Cash from Investing Activities value was -$222000.0 (recorded in 2021), while the average stood at $1.1 million.
  • As far as peak fluctuations go, Candel Therapeutics' Cash from Investing Activities crashed by 10249.73% in 2021, and later surged by 11111.11% in 2023.
  • Candel Therapeutics' Cash from Investing Activities (Quarter) stood at $20.2 million in 2020, then crashed by 102.5% to -$504000.0 in 2021, then skyrocketed by 45.24% to -$276000.0 in 2022, then surged by 90.22% to -$27000.0 in 2023.
  • Its Cash from Investing Activities was -$27000.0 in Q4 2023, compared to -$103000.0 in Q3 2023 and -$169000.0 in Q2 2023.